TrialAIDS (London, England)2010

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.

Marisa Tungsiripat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.